RBC Capital analyst Brian Abrahams maintained a Hold rating on SAGE Therapeutics (SAGE – Research Report) yesterday and set a price target of ...

RBC Capital analyst Ben Hendrix maintained a Buy rating on Humana (HUM – Research Report) yesterday and set a price target of $283.00. The ...

Fintel reports that on February 10, 2025, RBC Capital downgraded their outlook for Pliant Therapeutics (NasdaqGS:PLRX) from ...

Coca-Cola's Q4 exceeded expectations amid strong "fundamentals" despite currency headwinds and a market share grab from its ...

EOG Resources Inc. (NYSE:EOG) received an upgraded stock rating from RBC Capital Markets, moving from Sector Perform to Outperform. Alongside the rating change, EOG Resources also saw its price target ...

RBC Capital lowered the firm’s price target on PepsiCo (PEP) to $164 from $172 and keeps a Sector Perform rating on the ...

In a note to clients, the analysts at RBC Capital Markets argued that an extended period of tariffs could lead to higher ...

RBC Capital raised the firm’s price target on Affirm (AFRM) to $81 from $67 and keeps a Sector Perform rating on the shares. The company delivered a strong quarter with beats across the board and an ...

RBC Capital Markets analyst Bish Koziol made eight changes to his quantitatively driven top 40 list of stock picks. Maple ...

We recently compiled a list of the 11 Best Gig Economy Stocks to Buy According to Hedge Funds. In this article, we are going ...